Decoy Therapeutics Earnings & Forecasts - Benzinga

Decoy Therapeutics Inc

DCOYNASDAQ

Trade with Public

Trade with Public

$3.10

0.5421.09%

가까이에: Sep 22, 5:00 PM EST

$3.74

0.6420.65%

시간외: 7:59 PM EST

PRO

변동 이유?:Decoy Therapeutics shares are trading higher after the company announced a ...

개요 뉴스실적 전망이벤트 목표가 재무 심리 비교 주식 보고서

Decoy Therapeutics Earnings & Forecasts

Decoy Therapeutics (DCOY) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

Decoy Therapeutics Guidance

Recent Earnings Results

Metric	Q2 '26	Q1 '26	FY '25
Earnings Per Share (Non-GAAP)
Estimate	$-2.88	$-4.08	$-12.96
Actual	$-4.46	$-4.18	$-129.10
Surprise	-54.9%	-2.45%	-896.1%
Revenue
Estimate	—	—	—
Actual	$227629	$0	$0
Surprise	—	—	—

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q2 '26	Q1 '26	FY '25
Earnings Per Share (Non-GAAP)
Estimate	$-2.88	$-4.08	$-12.96
Actual	$-4.46	$-4.18	$-129.10
Surprise	-54.9%	-2.45%	-896.1%
Revenue
Estimate	—	—	—
Actual	$227629	$0	$0
Surprise	—	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

PRO
Decoy Therapeutics Q1 EPS $(4.18) Misses $(4.08) Estimate

Decoy Therapeutics (NASDAQ:DCOY) reported quarterly losses of $(4.18) per share which missed the analyst consensus estimate of $(4.08) by 2.45 percent. This is a 98.26 percent increase over losses of $(240.07) per share

Benzinga Newsdesk